NY

Najarmohammed Yusuf Sheliya

Active Director Director DIN 06877251
DIN 06877251 First appointment Jun 2014 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 6 active board seats
Past companies 1 historical roles
Total affiliations 7 Since Jun 2014
Shareholding value •••• Premium profile

About Najarmohammed Yusuf Sheliya

Data last updated:

Najarmohammed Yusuf Sheliya is a Director at Homeo Cure Private Limited (since 2014), Director at Avitel Post Studioz Limited (since 2015) and Director at Avitel Media Solutions Limited (since 2014), and holds 3 more current directorships. The companies operate in Healthcare, Media and Publishing and Telecommunication. The 2 current companies with reported revenue have a combined latest revenue of ₹4.1 Lakh; the largest is Homeo Cure Private Limited at ₹2.3 Lakh (FY 2025). Earlier, Najarmohammed Yusuf Sheliya was a Director at Living Force Healthcare Private Limited (2014–2019).

DIN 06877251
Primary Designation Director
Industry Healthcare
First Appointment 02 Jun 2014
Oldest Company Age 35 yrs
Largest company Homeo Cure Private Limited · ₹2.3 Lakh (FY 2025)
Combined revenue ₹4.1 Lakh across 2 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Homeo Cure Private Limited U33111MH2011PTC218078
Director02 Jun 20142011₹2.3 Lakh (FY 2025)Active
Avitel Post Studioz Limited U32200MH2000PLC126562
Director10 Apr 20152000₹1.9 Lakh (FY 2025)Active
Avitel Media Solutions Limited U32305MH1991PLC063278
Director02 Jun 20141991Active
Designated Partner03 Jul 20192019Active
Ihomeo Technologies Private Limited U74900MH2015PTC267946
Director31 Aug 20152015Active
Avitel Power Technologies Limited U74999MH2008PLC177218
Director02 Jun 20142008Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director02 Jun 20142011Converted To Llp

Explore Director's current and past company associations Uncover their professional journey today!

Board colleagues of Najarmohammed Yusuf Sheliya

Directorship timeline

Open interactive timeline →
Living Force Healthcare Llp
Avitel Media Solutions Limited
Homeo Cure Private Limited
Ihomeo Technologies Private Limited
Premium access

Shareholding and investment profile for Najarmohammed Yusuf Sheliya

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Najarmohammed Yusuf Sheliya

Najarmohammed Yusuf Sheliya currently holds 6 directorships: Homeo Cure Private Limited (Director, since 02 Jun 2014, revenue ₹2.3 Lakh (FY 2025)); Avitel Post Studioz Limited (Director, since 10 Apr 2015, revenue ₹1.9 Lakh (FY 2025)); Avitel Media Solutions Limited (Director, since 02 Jun 2014); Living Force Healthcare Llp (Designated Partner, since 03 Jul 2019); Ihomeo Technologies Private Limited (Director, since 31 Aug 2015); and 1 more.

Najarmohammed Yusuf Sheliya was first appointed on 02 Jun 2014 as Director at Homeo Cure Private Limited. The most recent appointment on record is 03 Jul 2019 at Living Force Healthcare Llp.

The 2 current companies of Najarmohammed Yusuf Sheliya that report revenue have a combined latest revenue of ₹4.1 Lakh: Homeo Cure Private Limited ₹2.3 Lakh (FY 2025); Avitel Post Studioz Limited ₹1.9 Lakh (FY 2025).

Najarmohammed Yusuf Sheliya held 1 earlier board appointment: Living Force Healthcare Private Limited (Director, 02 Jun 2014 to 02 Jul 2019).

The current boards of Najarmohammed Yusuf Sheliya's companies include Pradeep Shanti Pershad Jain (Homeo Cure Private Limited), Hrishi Pradeep Jain (Avitel Post Studioz Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available